Literature DB >> 2941541

Functional-morphological studies on in vitro cardionatrin release.

A J de Bold, M L de Bold, I R Sarda.   

Abstract

Atrial natriuretic peptides (ANP) are hormones produced by the heart atrial cardiocytes in mammals. The main function of these peptides appears to be that of modulating the actions of the renin-angiotensin-aldosterone system. In the rat ANP are stored within specific atrial granules, mainly as a 126-amino acid peptide (cardionatrin IV) which is processed to a 28-amino acid peptide (cardionatrin I) just prior to or during release from cardiocytes. Development of an isolated perifused rat atria preparation has allowed quantitative and qualitative studies on ANP release. Increasing mechanical load in this preparation gives an increased rate of release of immunoreactive cardionatrin. This finding suggests that there is an intrinsic 'stretch-secretion coupling' in the atria.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2941541

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  9 in total

1.  Serum atrial natriuretic peptide (ANP) as an objective indicator for the diagnosis of neurogenic shock: animal experiment and human case report.

Authors:  Min-Zhu Zhao; Yong-Guo Li; Peng Zhang; Jin-Cheng Xiong; Shi-Sheng Zhu; Xuan Xiao; Jian-Bo Li
Journal:  Int J Legal Med       Date:  2016-10-10       Impact factor: 2.686

2.  Effect of ryanodine on atrial natriuretic peptide secretion by contracting and quiescent rat atrium.

Authors:  M Laine; M Weckström; O Vuolteenaho; O Arjamaa
Journal:  Pflugers Arch       Date:  1994-02       Impact factor: 3.657

3.  Role of atrial natriuretic peptide in the development of arterial hypertension in patients with pubertal hypothalamic syndrome.

Authors:  T P Krivchenko; N I Verbovaya
Journal:  Neurosci Behav Physiol       Date:  1998 Jul-Aug

4.  Effects of the administration of thyroid hormone on the plasma levels of atrial natriuretic peptides and on atrial myoendocrine cells in the rat: an immunochemical, ultrastructural, and stereological study.

Authors:  G Cavallini; A Clerico; M Del Chicca; V De Tata; Z Gori; E Bergamini
Journal:  J Endocrinol Invest       Date:  1992-11       Impact factor: 4.256

5.  Reduced ability of C-type natriuretic peptide (CNP) to activate natriuretic peptide receptor B (NPR-B) causes dwarfism in lbab -/- mice.

Authors:  Andrea R Yoder; Andrew C Kruse; Cathleen A Earhart; Douglas H Ohlendorf; Lincoln R Potter
Journal:  Peptides       Date:  2008-05-08       Impact factor: 3.750

6.  Recruitment of the left ventricle for production of atrial natriuretic factor in Dahl salt-hypertension sensitive rats.

Authors:  J P Rapp; H Dene
Journal:  Cardiovasc Drugs Ther       Date:  1988-11       Impact factor: 3.727

Review 7.  Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure.

Authors:  Lauren B Arendse; A H Jan Danser; Marko Poglitsch; Rhian M Touyz; John C Burnett; Catherine Llorens-Cortes; Mario R Ehlers; Edward D Sturrock
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

Review 8.  Current and emerging drug targets in heart failure treatment.

Authors:  Nicolò Ghionzoli; Francesco Gentile; Anna Maria Del Franco; Vincenzo Castiglione; Alberto Aimo; Alberto Giannoni; Silvia Burchielli; Matteo Cameli; Michele Emdin; Giuseppe Vergaro
Journal:  Heart Fail Rev       Date:  2021-07-17       Impact factor: 4.654

Review 9.  The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment.

Authors:  Massimo Volpe; Marino Carnovali; Vittoria Mastromarino
Journal:  Clin Sci (Lond)       Date:  2016-01       Impact factor: 6.124

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.